Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo

BSE1193.7021.2 (+1.81 %)

PREV CLOSE ( ) 1172.50

OPEN PRICE ( ) 1171.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 12937

TODAY'S LOW / HIGH ( )1169.65 1199.40

52 WK LOW / HIGH ( )994.35 1364.95

NSE1195.1022.9 (+1.95 %)

PREV CLOSE( ) 1172.20

OPEN PRICE ( ) 1175.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1195.10 (1112)

VOLUME 670100

TODAY'S LOW / HIGH( ) 1170.40 1199.50

52 WK LOW / HIGH ( )1010 1356.2

Chairman	Mangalam Ramasubramanian Kumar
Managing Director	K Nityananda Reddy
Company Secretary	B Adi Reddy
Promoter & Non-Executive Director	PV Ramprasad Reddy
Non Executive Independent Director	Santanu Mukherjee Girish Paman Vanvari Deepali Pant Joshi
Whole Time Director	M Madan Mohan Reddy
Non Independent & Non Executive Director	P Sarath Chandra Reddy Satakarni Makkapati

Incorporation Year : 26-12 1986

Registered Office :

Address : Plot No. 2,Maitrivihar ,Ameerpet Hyderabad,
Telangana-500038 .

Phone : 040-23736370 / 23747340

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE